Name: 2018 Antibody Therapeutics Conference
Start: 2018-12-04T09:00:00+08:00
End: 2018-12-04T17:30:00+08:00
Location: 國家生技研究園區 C棟國際會議廳

Antibody Therapeutics Conference (ATC) 2018

~ Immuno-Oncology and Beyond~

主辦單位：

The Antibody Therapeutics Conference (ATC) is held by Taiwan Antibody Association. Over the past five years, the ATC has grown into a premier annual event which provides scientists and experts with an opportunity to face-to-face discuss the comprehensive scientific knowledge and experiences on how to develop therapeutic antibodies from discovery, development to commercialization.

We sincerely thank you for supporting the ATC and bringing your expertise to build a better tomorrow of the world well-being.

台灣抗體協會將於2018年12月4日(星期二)於國家生技研究園區 (C棟)國際會議廳舉辦「2018 Antibody Therapeutics Conference Immuno-Oncology, and Beyond」。抗體協會自2013年舉辦第一屆ATC論壇，自今已第五個年頭，這幾年各國皆如火如荼地投入抗體治療的應用與開發，也有不少成功的進程，台灣當然也不例外，可以感受到產、官、學、研積極投入。除了新標的抗體的開發，如何有效連結產業鏈，成為台灣學研機構共同面臨的課題。

今年的論壇探討關於當前趨勢和未來機會，期待透過您的參與討論，能夠讓論壇更加精采可期。

Time	Topic and Speaker
08:30 - 09:00	Registration
09:00 - 09:05	Opening Remarks Lawrence Gan, Ph.D Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals
09:05 - 09:10	Herbert Wu, Ph.D. President, Development Center for Biotechnology
Opening Keynote
Moderator 09:10 - 09:15	Andrew H.-J. Wang, Ph.D. Distinguished Visiting Chair, Institute of Biological Chemistry, Academia Sinica; President, IUBMB
09:15 - 10:00	Cancer Cell Cast a Sweet Spell on Tumor Microenvironment: Opportunities and Challenges Alice Yu, M.D., Ph.D. Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital
10:00 - 10:30	Break
Moderator 10:30 - 10:35	Shie-Liang Edmond Hsieh, M.D., D.Phil. Distinguished Research Fellow, Genomics Research Center, Academia Sinica
10:35 - 11:05	What You Eat Makes You Strong but Vulnerable : Metabolic Targeting of Intramural Tregs in Cancer Immunotherapy Ping-Chih Ho, Ph.D. Assistant Professor/Ludwig adjunct scientist Department of oncology UNIL CHUV/Ludwig Institute for Cancer Research Lausanne
11:35 - 12:05	Finding Better Combinations of Immunotherapy Keng-Li Lan, M.D., Ph.D. Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital
12:05 - 13:40	Lunch (Taiwan Antibody Association Members Meeting and Poster Viewing)
12:15 - 12:45	Lunch Panel / Industry satellite symposium
Moderator 13:40 - 13:45	Ping-Ning Hsu, M.D., Ph.D. Professor, Graduate Institute of Immunology, College of Medicine, National Taiwan University
13:45 - 14:15	Understanding Immune Checkpoint TIM-3 Biology and TIM-3 Antibody for Cancer Immunotherapy Xiaomo Jiang , Ph.D. Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
14:15 - 14:45	Clinical Experience and Safety Management of Immunotherapy John Wen-Cheng Chang, M.D. Chief, Division of Medical Oncology, Chang Gung Memorial Hospital; Director, Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital; Chairman, Taiwan Society for Immunotherapy of Cancer
14:45 - 15:15	Current Progress of Immunotherapy for Non-small Cell Lung Cancer Chih-Hsin Yang, M.D., Ph.D. Professor & Director, Graduate Institute of Oncology, College of Medicine, National Taiwan University
15:15 - 15:45	Break
15:45 - 16:00	Poster Award
Closing Keynote
Moderator 16:00 - 16:05	Herbert Wu, Ph.D. President, Development Center for Biotechnology
16:05 - 16:50	Engineering Adaptive Cell and Gene Therapies Timothy K. Lu, Ph.D. Associate Professor Synthetic Biology Group, Research Laboratory of Electronics, Electrical Engineering and Computer Science, Biological Engineering, Massachusetts Institute of Technology
16:50 - 17:00	Closing Remarks Herbert Wu, Ph.D. President, Development Center for Biotechnology

2018 Antibody Therapeutics Conference

線下活動

線下活動

活動嘉賓